Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for prevention of nausea and pruritus after intrathecal fentanyl in lower limb orthopedic surgery
IRCT20160307026950N47Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ondansetron in nausea ((none)) and pruritus (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Nausea and Pruritus. Started Sep 2022; status: completed.
02
Drugs
ondansetron
03
Conditions
nausea ((none))pruritus
Beyond the preview
Go deeper on IRCT20160307026950N47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N47.